Guest Editors Jeffrey Bishop and Vicki Ellingrod discuss Pharmacotherapy's themed issue on Precision Medicine

Drs. Tran and DeVane discuss the prevalence and treatment of opioid use disorder in pregnancy.

Dr. Douglas Jennings reviews inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction s/p LVAD or CTX.

Dr. Candice Garwood provides insight into bridge therapy for patients using vitamin K antagonists for atrial fibrillation.

Dr. Michael J. Rybak discusses Enterococcus faecium infections and the use of new and old treatment regimens, including combination therapy.

Clinical Pharmacist Competencies: Drs. Saseen and Seaton discuss the new ACCP guideline which describes six essential competency domains for clinical pharmacists.

SGLT2 Inhibitors: Drs. Nuffer and Trujillo discuss the nonglycemic outcomes, clinical implications, and adverse effects associated with SGLT2 inhibitor therapy in patients with type 2 diabetes.

This episode features clinical queries posed by ACCP members. Our experts, James Coons from the University of Pittsburgh, Zach Stacey from St. Louis College of Pharmacy, and Jessica Tilton from the University of Illinois answer questions on a variety of different topics including various uses of amiodarone, ranolazine, sotalol, and ivabradine.

Antimicrobial dosing in pediatric obesity. Drs. Le and Natale discuss their review article "Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing" published in the March 2017 issue of Pharmacotherapy.

The pediatric obesity epidemic. Drs. Le and Natale discuss their review article "Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing" published in the March 2017 issue of Pharmacotherapy.